Ronald W. Barrett
CIK: 0001326330
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JANX
Janux Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Barrett Ronald W
Barrett Ronald W (SEC CIK 0001326330) files insider reports with the SEC as Director of Janux Therapeutics, Inc. (JANX).
Signal8 holds 2 ownership filings by Barrett Ronald W, all Form 4s, filed between Jun 13, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Barrett Ronald W's filings is in SAN DIEGO, CA.
Recent filings by Barrett Ronald W
Other insiders filing for Janux Therapeutics, Inc. (JANX)
- Campbell David Alan, President and CEO
- RA CAPITAL MANAGEMENT, L.P., Director
- Simson Jake, Director
- Kung Winston, Director
- Hernday Natasha, Director
- DOBMEIER ERIC, Director